Organism name | Caragana frutex |
---|---|
Genus | Caragana |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Caragana frutex |
---|---|
Linked NCBI taxonomy ID | 47643 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00004635
![]() |
Isorhamnetin
/ 3'-O-Methylquercetin / 3,4',5,7-Tetrahydroxy-3'-methoxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL379064
|
C047368
|
12 / 10 / 13 | 10 / 0 | No. 3 | No. 15 |
![]() |
C00001071
![]() |
Myricetin
|
CHEMBL164
|
C040015
|
78 / 70 / 56 | 39 / 2 | No. 3 | No. 15 |
![]() |
C00002547
![]() |
(-)-Medicarpin
/ 3-Hydroxy-9-methoxypterocarpan |
CHEMBL238845
CHEMBL413297 |
C047353
|
3 / 1 / 1 | No. 66 | No. 15 |
![]() |
|
C00002546
![]() |
Inermin
/ Maackiain / (-)-Maackiain / Demethylpterocarpin / 3-Hydroxy-8,9-methylenedioxypterocarpan |
CHEMBL334918
CHEMBL239047 CHEMBL445279 |
3 / 2 / 3 | No. 66 | No. 15 |
![]() |
||
C00002499
![]() |
Scopoletin
|
CHEMBL71851
|
D012603
|
48 / 37 / 34 | 9 / 0 | No. 864 | No. 25 |
![]() |
C00000576
![]() |
Xanthotoxin
|
CHEMBL416
|
D008730
|
104 / 55 / 45 | 22 / 18 | No. 1282 | No. 25 |
![]() |
C00000575
![]() |
Bergaptan
|
CHEMBL24171
|
C022909
|
22 / 22 / 17 | 0 / 3 | No. 1282 | No. 25 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000575 C00000576 C00001071 C00002499 C00002546 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000575 C00000576 C00001071 C00002499 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000575 C00000576 C00001071 C00002499 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000575 C00000576 C00001071 C00002499 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000576 C00001071 C00002499 C00004635 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001071 C00002499 C00004635 | 1 / 2 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000575 C00001071 C00002499 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000575 C00000576 C00002499 | 7 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000575 C00000576 C00001071 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000575 C00001071 C00002499 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000576 C00001071 C00002499 | 0 / 3 |
O00255 | Menin | Unclassified protein | C00001071 C00002499 C00004635 | 2 / 5 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00001071 C00002499 C00004635 | 1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00000576 C00001071 C00002499 | 1 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000575 C00001071 C00002499 | 3 / 3 |
P56817 | Beta-secretase 1 | A1A | C00000575 C00000576 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001071 C00002499 | 2 / 2 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002499 C00004635 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000576 C00001071 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001071 C00004635 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000575 C00002547 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001071 C00002499 | 1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | C00001071 C00004635 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00001071 C00004635 | 4 / 4 |
P10275 | Androgen receptor | NR3C4 | C00000575 C00000576 | 3 / 4 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001071 C00004635 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001071 C00002499 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00001071 C00002499 | 6 / 4 |
P15121 | Aldose reductase | Enzyme | C00001071 C00002499 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002499 C00002547 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001071 C00004635 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000576 C00002499 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001071 C00002499 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000575 C00000576 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001071 C00002499 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000576 C00001071 | 2 / 3 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001071 C00002499 | 0 / 0 |
Q09470 | Potassium voltage-gated channel subfamily A member 1 | KCNA, Kv1.x (Shaker) | C00000575 C00000576 | 1 / 1 |
P20813 | Cytochrome P450 2B6 | Cytochrome P450 2B6 | C00000575 C00000576 | 1 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00001071 C00004635 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000576 C00002499 | 1 / 2 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000576 C00002547 | 1 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000575 C00000576 | 3 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00001071 | 5 / 2 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001071 | 0 / 0 |
P17658 | Potassium voltage-gated channel subfamily A member 6 | K | C00000575 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000576 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000576 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000576 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000576 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000576 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00001071 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00001071 | 0 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00000575 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000576 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000576 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000576 | 0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002499 | 0 / 0 |
P23443 | Ribosomal protein S6 kinase beta-1 | p70 | C00000576 | 0 / 0 |
P04792 | Heat shock protein beta-1 | Unclassified protein | C00004635 | 2 / 1 |
P54132 | Bloom syndrome protein | Enzyme | C00001071 | 1 / 2 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00001071 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001071 | 1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000576 | 1 / 8 |
P11387 | DNA topoisomerase 1 | Isomerase | C00001071 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00001071 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000576 | 2 / 2 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000576 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000576 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000576 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000576 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000576 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000576 | 0 / 0 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | C00001071 | 1 / 1 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000576 | 0 / 0 |
P16389 | Potassium voltage-gated channel subfamily A member 2 | KCNA, Kv1.x (Shaker) | C00000575 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00001071 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000576 | 1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001071 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000576 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000576 | 1 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002499 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002499 | 1 / 2 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00001071 | 1 / 1 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000576 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000576 | 0 / 0 |
P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | C00001071 | 9 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002499 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002499 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00002499 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002499 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000576 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000576 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000576 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000576 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000576 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000576 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000576 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002499 | 1 / 1 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000576 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000576 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000576 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002499 | 0 / 0 |
Q14790 | Caspase-8 | C14 | C00001071 | 2 / 1 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000576 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000576 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000576 | 1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000576 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000576 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000576 | 0 / 0 |
P22001 | Potassium voltage-gated channel subfamily A member 3 | KCNA, Kv1.x (Shaker) | C00000575 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00002499 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001071 | 1 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00001071 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00001071 | 3 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001071 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000576 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00001071 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00001071 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00000576 | 1 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001071 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000576 | 0 / 1 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00001071 | 5 / 4 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000576 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000576 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001071 | 2 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000576 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000576 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000576 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000576 | 1 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000576 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000576 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00001071 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000576 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000576 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000576 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002499 | 1 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000576 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001071 | 2 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000576 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000576 | 0 / 0 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00001071 | 0 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000576 | 2 / 1 |
P08246 | Neutrophil elastase | S1A | C00000576 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000576 | 2 / 2 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002499 | 0 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001071 | 2 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001071 | 1 / 1 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002499 | 0 / 0 |
P55789 | FAD-linked sulfhydryl oxidase ALR | Enzyme | C00002499 | 1 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000576 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00002499 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002499 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000576 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000576 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000576 | 1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000576 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000576 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000576 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000576 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000576 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000576 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000576 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000576 | 0 / 0 |
Q00796 | Sorbitol dehydrogenase | Enzyme | C00002499 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00001071 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001071 | 0 / 0 |
P55210 | Caspase-7 | C14 | C00002499 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001071 | 0 / 0 |
P31941 | DNA dC->dU-editing enzyme APOBEC-3A | Enzyme | C00001071 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000576 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001071 | 0 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | C00001071 | 2 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001071 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00000576 | 1 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002499 | 5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001071 | 4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001071 | 0 / 0 |
P48547 | Potassium voltage-gated channel subfamily C member 1 | K | C00000575 | 0 / 0 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00002499 | 1 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000576 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000576 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000576 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000576 | 0 / 1 |
P22460 | Potassium voltage-gated channel subfamily A member 5 | KCNA, Kv1.x (Shaker) | C00000575 | 1 / 1 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00001071 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000576 | 0 / 0 |
P31639 | Sodium/glucose cotransporter 2 | Glucose | C00002546 | 1 / 1 |
P13866 | Sodium/glucose cotransporter 1 | Glucose | C00002546 | 1 / 1 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00002499 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001071 | 1 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002499 | 3 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001071 | 1 / 1 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00001071 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001071 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001071 | 1 / 4 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001071 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001071 | 2 / 1 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001071 | 0 / 0 |
Q9HCT0 | Fibroblast growth factor 22 | Unclassified protein | C00001071 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000576
C00001071
C00004635
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000576
C00001071
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001071
C00004635
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000576
C00001071
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000576
C00001071
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000576
C00001071
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000576
C00001071
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001071
C00004635
|
1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) |
C00000576
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001071
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00001071
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001071
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00001071
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00001071
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001071
|
397 | ARHGDIB, D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 | Rho GDP dissociation inhibitor (GDI) beta |
C00001071
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00001071
|
54583 | EGLN1, C1orf12, ECYT3, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 | egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) |
C00001071
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00001071
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00001071
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00001071
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00001071
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001071
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00001071
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00001071
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00001071
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00001071
|
8505 | PARG, PARG99 | poly (ADP-ribose) glycohydrolase (EC:3.2.1.143) |
C00001071
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001071
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00001071
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001071
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001071
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00001071
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00001071
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001071
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00001071
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00001071
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00001071
|
7161 | TP73, P73 | tumor protein p73 |
C00001071
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004635
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004635
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00004635
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004635
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00004635
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00004635
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004635
|
8553 | BHLHE40, BHLHB2, DEC1, HLHB2, SHARP-2, STRA13, Stra14 | basic helix-loop-helix family, member e40 |
C00000576
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00000576
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000576
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000576
|
8824 | CES2, CE-2, CES2A1, PCE-2, iCE | carboxylesterase 2 (EC:3.1.1.1 3.1.1.84 3.1.1.56) |
C00000576
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000576
|
891 | CCNB1, CCNB | cyclin B1 |
C00001071
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00000576
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000576
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00000576
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000576
|
3034 | HAL, HIS, HSTD | histidine ammonia-lyase (EC:4.3.1.3) |
C00000576
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000576
|
3355109 |
C00000576
|
||
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000576
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000576
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002499
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002499
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002499
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00002499
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002499
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002499
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002499
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00002499
|
7508 | XPC, RAD4, XP3, XPCC | xeroderma pigmentosum, complementation group C |
C00002499
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#612240 | Atrial fibrillation, familial, 7; atfb7 |
P22460
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#114480 | Breast cancer |
P42336
|
#300615 | Brunner syndrome |
P21397
|
#607271 | Caspase 8 deficiency |
Q14790
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#606595 | Charcot-marie-tooth disease, axonal, type 2f; cmt2f |
P04792
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P18054
P42336 Q14191 |
#612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
#615108 | Cowden syndrome 5; cws5 |
P42336
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#614546 | Efavirenz, poor metabolism of |
P20813
|
#160120 | Episodic ataxia, type 1; ea1 |
Q09470
|
#133239 | Esophageal cancer |
P18054
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#606824 | Glucose/galactose malabsorption; ggm |
P13866
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#114550 | Hepatocellular carcinoma |
P42336
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#182000 | Keratosis, seborrheic |
P42336
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 Q14790 |
#608516 | Major depressive disorder; mdd |
P08172
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
#603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay |
P55789
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#608634 | Neuronopathy, distal hereditary motor, type iib; hmn2b |
P04792
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
P42336 |
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#233100 | Renal glucosuria; glys1 |
P31639
|
#607276 | Resting heart rate, variation in |
P08588
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
P42336 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00856 | Distal hereditary motor neuropathies (dHMN) |
P04792
(related)
|
H00213 | Hypophosphatasia |
P05186
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01261 | Congenital glucose-galactose malabsorption (GGM) |
P13866
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00731 | Atrial fibrillation |
P22460
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P28907
(marker)
|
H01126 | Familial renal glucosuria (FRG) |
P31639
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
Q01453
(related)
Q15046 (related) |
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00749 | Episodic ataxias |
Q09470
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00108 | Autoimmune lymphoproliferative syndromes (ALPS) |
Q14790
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D011565 | Psoriasis |
C00000575
C00000576 |
D008175 | Lung Neoplasms |
C00000576
|
D006505 | Hepatitis |
C00000575
|
D005909 | Glioblastoma |
C00001071
|
D009203 | Myocardial Infarction |
C00001071
|
D015746 | Abdominal Pain |
C00000576
|
D056486 | Drug-Induced Liver Injury |
C00000576
|
D004485 | Eczema |
C00000576
|
D006261 | Headache |
C00000576
|
D007674 | Kidney Diseases |
C00000576
|
D017114 | Liver Failure, Acute |
C00000576
|
D010787 | Photosensitivity Disorders |
C00000575
|
D016410 | Lymphoma, T-Cell, Cutaneous |
C00000576
|
D008881 | Migraine Disorders |
C00000576
|
D009182 | Mycosis Fungoides |
C00000576
|
D009325 | Nausea |
C00000576
|
D000857 | Olfaction Disorders |
C00000576
|
D011693 | Purpura |
C00000576
|
D007319 | Sleep Initiation and Maintenance Disorders |
C00000576
|
D014006 | Tinea Capitis |
C00000576
|
D015837 | Vestibular Diseases |
C00000576
|
D014820 | Vitiligo |
C00000576
|